Tezspire® (tezepelumab-ekko)
for Asthma

Tezspire (tezepelumab-ekko) is an injectable biologic used for the maintenance treatment of severe asthma in individuals 12 years and older whose asthma is not controlled with standard treatments. It is a thymic stromal lymphopoietin (TSLP) blocker and the only biologic approved for severe asthma without phenotype or biomarker limitations. Tezspire helps prevent asthma attacks and improve breathing but is not a rescue medication for acute symptoms.

Heart
Medication Guide Icon Medication Guide
TV Commercial Icon TV Commercial
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Asthma